## Histological Types of Colorectal Carcinoma **Key Point:** Signet ring cell carcinoma is the most aggressive histological variant of colorectal cancer, with the poorest prognosis and frequent association with mismatch repair (MMR) deficiency. ### Comparison of Histological Variants | Histological Type | Frequency | Prognosis | Key Features | MSI Status | |-------------------|-----------|-----------|--------------|------------| | Tubular adenocarcinoma | 60–70% | Intermediate | Well-differentiated glands | MSS (usually) | | Mucinous adenocarcinoma | 10–15% | Poor | >50% extracellular mucin | MSI-H (40–50%) | | Signet ring cell | 1–3% | **Worst** | **>50% cells with mucin vacuoles** | **MSI-H (70–80%)** | | Enteric adenocarcinoma | Rare | Intermediate | Resembles small bowel carcinoma | Variable | **High-Yield:** Signet ring cell carcinoma: - Accounts for only 1–3% of colorectal cancers - Presents at advanced stage (Stage III–IV in >80% of cases) - 5-year survival: ~5–15% (vs. ~65% for all colorectal cancers) - Strongly associated with **Lynch syndrome** (hereditary non-polyposis colorectal cancer, HNPCC) and MMR gene mutations - Often shows **microsatellite instability (MSI-H)** due to defective mismatch repair **Clinical Pearl:** Signet ring cells are characterized by a large mucin vacuole that displaces the nucleus to the periphery, creating a "signet ring" appearance on histology. These tumours are diffuse, infiltrative, and often involve the entire bowel wall, making them difficult to treat surgically. **Mnemonic:** **SRC = Signet Ring = Severe prognosis** (remember: Signet Ring Carcinoma is the worst). ### Why Signet Ring Cell Carcinoma is Most Aggressive 1. **Diffuse infiltration** — tumour cells are scattered throughout the submucosa and muscularis, not confined to glands 2. **MMR deficiency** — leads to hypermutability and increased genomic instability 3. **Early invasion** — often invades beyond the muscularis propria at diagnosis 4. **Limited surgical options** — diffuse nature may require total colectomy; margins are difficult to achieve 5. **Chemoresistance** — paradoxically, MSI-H tumours may respond poorly to 5-FU-based chemotherapy [cite:Robbins 10e Ch 17]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.